Clestra Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 26-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 26-06-2024
- Company Age 26 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.00 Cr
as on 26-06-2024
- Revenue 83.18%
(FY 2017)
- Profit 122.96%
(FY 2017)
- Ebitda -100.26%
(FY 2017)
- Net Worth 6.16%
(FY 2017)
- Total Assets 1.90%
(FY 2017)
About Clestra Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹3.00 Cr.
Managobinda Dalai and Raunit Rathor serve as directors at the Company.
- CIN/LLPIN
U24239MH1998PTC113218
- Company No.
113218
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 1998
- Date of AGM
25 Aug 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Clestra Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Managobinda Dalai  | Additional Director | 25-May-2021 | Current |
| Raunit Rathor | Additional Director | 25-May-2021 | Current |
Financial Performance of Clestra Life Sciences.
Clestra Life Sciences Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 83.18% increase. The company also saw a substantial improvement in profitability, with a 122.96% increase in profit. The company's net worth moved up by a moderate rise of 6.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clestra Life Sciences?
In 2017, Clestra Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Genom Biotech Private LimitedActive 24 years 10 monthsManagobinda Dalai and Raunit Rathor are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 22 Nov 2001 | ₹3.00 Cr | Open |
How Many Employees Work at Clestra Life Sciences?
Unlock and access historical data on people associated with Clestra Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clestra Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clestra Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
